相关实验视频
Updated: Jun 24, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
数字双胞胎:重新想象心血管风险预测和个性化护理的未来
Katarzyna Dziopa1, Karim Lekadir2, Pim van der Harst3
1Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, Netherlands; Institute of Health Informatics, University College London, London, United Kingdom; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, United Kingdom.
通用人工智能和数字生可以通过创建个性化的虚拟患者模型来彻底改变心血管疾病预防. 这种方法加速了准确医学,用于早期风险检测和改善健康结果.
科学领域:
- 生物医学工程 生物医学工程
- 人工智能在医学中的应用
- 心血管疾病研究研究
背景情况:
- 数字生结合了多种数据源,以创建单独的虚拟模型.
- 人工智能 (AI) 的进步,特别是通用AI,使各种医疗数据类型的处理成为可能.
- 通用AI模型可以适应新的医疗任务,并提供可解释的输出.
研究的目的:
- 探索数字生与通用AI之间的协同作用,以预防心血管风险.
- 突出这种综合方法在推进精准医学方面的潜力.
主要方法:
- 使用高度适应和可重复使用的通用AI模型.
- 整合来自电子健康记录,实验室结果,医学文本,成像和基因组学数据的数据.
- 利用人工智能的能力来推理和解释使用医学知识的输出.
主要成果:
- 拟议的战略有助于实施数字生,以获得个性化的健康见解.
- 通用人工智能增强了复杂的多模式患者数据的处理和解释.
- 这种结合加快了精确心血管医学的发展.
结论:
- 数字生与通用人工智能的整合为心血管风险预防提供了一个变革性的途径.
- 这一战略具有显著的潜力,可以提高早期识别和预防性干预.
- 该方法可以扩展到其他医学领域,推进预测,预防和精准医学,并促进健康研究.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Errors occurring during blood pressure monitoring
Several factors...

